glutamic acid and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

glutamic acid has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 36 studies

Research

Studies (36)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (5.56)	18.7374
1990's	9 (25.00)	18.2507
2000's	13 (36.11)	29.6817
2010's	10 (27.78)	24.3611
2020's	2 (5.56)	2.80

Authors

Authors	Studies
Kopin, IJ; Marini, AM; Schwartz, JP	1
Heikkila, RE; Nicklas, WJ; Vyas, I	1
Brotchie, JM; Crossman, AR; Maneuf, YP; Mitchell, IJ; Woodruff, GN	1
Lange, KW; Löschmann, PA; Turski, L; Wachtel, H	1
Chan, P; Di Monte, DA; Langston, JW	1
Altomare, C; Carotti, A; Carrupt, PA; Cellamare, S; Jenner, P; Marsden, CD; McNaught, KS; Testa, B; Thull, U	1
Hazell, AS; Itzhak, Y; Liu, H; Norenberg, MD	1
Beal, MF; Becker, DA; Klivenyi, P; MacGarvey, U; Matthews, RT; Natero, R; Wermer, M; Yang, L	1
Bezard, E; Bioulac, B; Boraud, T; Gross, CE	1
Cheng, FC; Dryhurst, G; Han, J; Yang, Z	1
Greenamyre, JT; MacKenzie, G; Peng, TI; Stephans, SE	1
Kryzhanovskii, GN; Kucheryanu, VG	1
Ferger, B; Schmidt, N	1
Araki, T; Imai, Y; Matsubara, M; Muramatsu, Y; Tanaka, K	1
Araki, T; Imai, Y; Itoyama, Y; Kato, H; Kumagai, T; Matsubara, M; Tanaka, K	1
Bédard, PJ; Blanchet, PJ; Calon, F; Di Paolo, T; Ghribi, O; Goulet, M; Grondin, R; Morissette, M	1
Freeman, P; Krentz, L; Meshul, CK; Moore, C; Robinson, S; Touchon, JC	1
Bonuccelli, U; Corsini, GU; Maggio, R; Pardini, C; Vaglini, F	1
Beales, M; Dervan, AG; McBean, GJ; Meredith, GE; Meshul, CK; Moore, C; Snyder, AK; Totterdell, S	1
Holmer, HK; Keyghobadi, M; Menashe, RA; Meshul, CK; Moore, C	1
Holmer, HK; Keyghobadi, M; Meshul, CK; Moore, C	1
Hu, XW; Li, BM; Li, FQ; Liu, HH; You, BM; Zhao, XD; Zhou, XP	1
Kostrzewa, RM	1
Raju, DV; Smith, Y; Villalba, RM	1
Deutch, AY; Garcia, BG; Neely, MD	1
Bielicki, G; Chassain, C; Durif, F; Keller, C; Renou, JP	1
Antipova, TA; Gudasheva, TA; Seredenin, SB	1
Aguiar, AS; Castro, AA; Ferreira, J; Figueiredo, CP; Matheus, FC; Prediger, RD; Santos, AR; Tasca, CI; Villarinho, JG; Walz, R	1
Hood, RL; Meshul, CK; Mitchell, SH; Pflibsen, L; Sconce, MD; Stang, KA; Wilson, VB	1
Bagga, P; Crescenzi, R; Detre, JA; Greenberg, J; Hariharan, H; Krishnamoorthy, G; Nanga, RP; Reddy, D; Reddy, R; Verma, G	1
Jain, R; Meena, CL; Pant, AB; Rajput, SK; Sharma, AK; Sharma, SS	1
He, X; Meng, X; Qu, S; Tong, H; Wu, X; Zhang, X; Zhang, Y	1
Bagga, P; Borthakur, A; Crescenzi, R; D'Aquilla, K; Detre, JA; Greenberg, J; Hariharan, H; Martinez, D; Pickup, S; Reddy, R; Singh, A; Verma, G	1
Li, A; Lu, M; Wang, R; Wen, Y; Xu, J; Zhao, X; Zhou, J	1
Kucheryanu, VG; Vetrile, LA; Voronina, NA; Zakharova, IA	1
Ağar, A; Akçay, G; Aydın Aslan, M; Bülbül, M; Derin, N; Özkan, A; Parlak, H; Sinen, O	1

Reviews

2 review(s) available for glutamic acid and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Article	Year
Mitochondrial dysfunction in Parkinson's disease. Biochemical Society symposium, 1999, Volume: 66 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Calcium; Disease Models, Animal; Dopamine; Electron Transport Complex I; Glutamic Acid; Humans; Mitochondria; NADH, NADPH Oxidoreductases; Neurons; Parkinson Disease; Rats; Reactive Oxygen Species	1999
Evolution of neurotoxins: from research modalities to clinical realities. Current protocols in neuroscience, 2009, Volume: Chapter 1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Animals; Benzylamines; Botulinum Toxins, Type A; Dihydroxyphenylalanine; Dihydroxytryptamines; Glutamic Acid; Humans; Models, Animal; Nerve Growth Factor; Neurosciences; Neurotoxins; Oxidopamine; Terminology as Topic	2009

Article

Year

Mitochondrial dysfunction in Parkinson's disease.

Biochemical Society symposium, 1999, Volume: 66

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Calcium; Disease Models, Animal; Dopamine; Electron Transport Complex I; Glutamic Acid; Humans; Mitochondria; NADH, NADPH Oxidoreductases; Neurons; Parkinson Disease; Rats; Reactive Oxygen Species

1999

Evolution of neurotoxins: from research modalities to clinical realities.

Current protocols in neuroscience, 2009, Volume: Chapter 1

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Animals; Benzylamines; Botulinum Toxins, Type A; Dihydroxyphenylalanine; Dihydroxytryptamines; Glutamic Acid; Humans; Models, Animal; Nerve Growth Factor; Neurosciences; Neurotoxins; Oxidopamine; Terminology as Topic

2009

Other Studies

34 other study(ies) available for glutamic acid and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Article	Year
The neurotoxicity of 1-methyl-4-phenylpyridinium in cultured cerebellar granule cells. The Journal of neuroscience : the official journal of the Society for Neuroscience, 1989, Volume: 9, Issue:10 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Aspartic Acid; Cells, Cultured; Cerebellum; Designer Drugs; Excitatory Amino Acid Antagonists; Glutamic Acid; Granulocytes; Monoamine Oxidase; Neurotoxins; Osmolar Concentration; Time Factors	1989
Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life sciences, 1985, Jul-01, Volume: 36, Issue:26 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine Diphosphate; Animals; Brain; Glutamates; Glutamic Acid; Malates; Male; Mice; Mitochondria; NAD; Neurotoxins; Oxidation-Reduction; Phosphorylation; Pyridines; Rats; Rats, Inbred Strains	1985
Functional implications of kappa opioid receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson's disease. Brain research, 1995, Jun-12, Volume: 683, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Arrhythmia Agents; Basal Ganglia; Benzofurans; Callithrix; Female; Glutamic Acid; In Vitro Techniques; Male; Motor Activity; Naltrexone; Parkinson Disease, Secondary; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reserpine; Synaptic Transmission	1995
MPTP-induced degeneration: interference with glutamatergic toxicity. Journal of neural transmission. Supplementum, 1994, Volume: 43 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Chromatography, High Pressure Liquid; Dopamine; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Piperazines; Receptors, N-Methyl-D-Aspartate; Serotonin	1994
Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutamate and aspartate in the mouse brain. Brain research, 1994, Jun-06, Volume: 647, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aspartic Acid; Brain Chemistry; Deoxyglucose; Energy Metabolism; Glutamic Acid; Male; Mazindol; Mice; Mice, Inbred C57BL; Receptors, N-Methyl-D-Aspartate; Selegiline	1994
Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration. Biochemical pharmacology, 1996, Jun-14, Volume: 51, Issue:11 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Ascorbic Acid; Glutamic Acid; Isoquinolines; Malates; Male; Mitochondria, Liver; Oxygen Consumption; Rats; Rats, Wistar; Rotenone; Structure-Activity Relationship; Succinates; Tetramethylphenylenediamine	1996
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) decreases glutamate uptake in cultured astrocytes. Journal of neurochemistry, 1997, Volume: 68, Issue:5 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Astrocytes; Cells, Cultured; Dopamine Agents; Dose-Response Relationship, Drug; Glutamic Acid; Osmolar Concentration; Rats	1997
Azulenyl nitrone spin traps protect against MPTP neurotoxicity. Experimental neurology, 1998, Volume: 152, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Azulenes; Brain Chemistry; Dopamine; Free Radicals; Glutamic Acid; Male; Mice; MPTP Poisoning; N-Methylaspartate; Neuroprotective Agents; Nitrogen Oxides; Oxidation-Reduction; Sesquiterpenes; Spin Labels	1998
Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms. The European journal of neuroscience, 1999, Volume: 11, Issue:6 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adaptation, Physiological; Animals; Dopamine Agents; Electrophysiology; Globus Pallidus; Glutamic Acid; Macaca fascicularis; Parkinson Disease, Secondary; Thalamic Nuclei	1999
Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease. Journal of neurochemistry, 1999, Volume: 73, Issue:4 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Cysteine; Glutamic Acid; Glutathione; Glycine; Hydrolysis; Hydroxyl Radical; Iron; Kinetics; Male; Microdialysis; Mitochondria; Models, Chemical; Nitro Compounds; Oxygen Consumption; Parkinson Disease; Perfusion; Propionates; Rats; Rats, Sprague-Dawley; Substantia Nigra	1999
Effect of glutamate and antagonists of N-methyl-D-aspartate receptors on experimental parkinsonian syndrome in rats. Bulletin of experimental biology and medicine, 2000, Volume: 130, Issue:7 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Excitatory Amino Acid Antagonists; Glutamic Acid; Ketamine; Male; Memantine; Parkinson Disease, Secondary; Rats; Receptors, N-Methyl-D-Aspartate	2000
Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease. Synapse (New York, N.Y.), 2001, Volume: 40, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anticonvulsants; Brain; Disease Models, Animal; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Neostriatum; Nerve Degeneration; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Pyrones; Substantia Nigra; Tyrosine 3-Monooxygenase	2001
Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice. Neuroscience letters, 2001, Oct-12, Volume: 312, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Astrocytes; Dopamine; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Excitatory Amino Acid Antagonists; Glial Fibrillary Acidic Protein; Glutamic Acid; Homovanillic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Neostriatum; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Riluzole; Substantia Nigra; Tyrosine 3-Monooxygenase	2001
Neuroprotective effect of riluzole in MPTP-treated mice. Brain research, 2001, Nov-09, Volume: 918, Issue:1-2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Glutamic Acid; Homovanillic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Neostriatum; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Riluzole; Substantia Nigra; Synaptic Transmission; Tyrosine 3-Monooxygenase	2001
Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment. Progress in neuro-psychopharmacology & biological psychiatry, 2002, Volume: 26, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzazepines; Corpus Striatum; Dopamine Agonists; Female; Glutamic Acid; Glutamine; Glycine; Macaca fascicularis; Ovariectomy; Parkinsonian Disorders; Receptors, Glutamate; Reference Values	2002
Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function. Experimental neurology, 2003, Volume: 180, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acute Disease; Animals; Chronic Disease; Corpus Striatum; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Glutamic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Microdialysis; Microscopy, Immunoelectron; Parkinson Disease, Secondary; Presynaptic Terminals; Protein Subunits; Receptors, Glutamate; Synapses; Tyrosine 3-Monooxygenase	2003
Dextromethorphan prevents the diethyldithiocarbamate enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice. Brain research, 2003, May-30, Volume: 973, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Chelating Agents; Dextromethorphan; Ditiocarb; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Glutamic Acid; Homovanillic Acid; Male; Mesencephalon; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurons; Septal Nuclei; Serotonin; Substantia Nigra; Tyrosine 3-Monooxygenase	2003
Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease. Experimental neurology, 2004, Volume: 190, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Astrocytes; Biological Transport; Cell Count; Cell Size; Chronic Disease; Disease Models, Animal; Disease Progression; Excitatory Amino Acid Transporter 2; Extracellular Fluid; Glial Fibrillary Acidic Protein; Gliosis; Glutamic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Neostriatum; Parkinsonian Disorders; Probenecid; Sodium; Synapses	2004
Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration. Synapse (New York, N.Y.), 2005, Volume: 57, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Caloric Restriction; Corpus Striatum; Disease Models, Animal; Dopamine; Down-Regulation; Excitatory Amino Acid Transporter 2; Extracellular Fluid; Food Deprivation; Glutamic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Microdialysis; Microscopy, Electron, Transmission; Nerve Degeneration; Neural Pathways; Parkinsonian Disorders; Presynaptic Terminals; Substantia Nigra; Synaptic Transmission; Tyrosine 3-Monooxygenase	2005
l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience, 2005, Volume: 136, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Excitatory Amino Acid Transporter 2; Glutamic Acid; Immunohistochemistry; Levodopa; Male; Mice; Mice, Inbred C57BL; Microdialysis; Microscopy, Immunoelectron; Substantia Nigra; Tyrosine 3-Monooxygenase	2005
[Changes of amino acids neurotransmitters in striatum of hemi-parkinsonian rhesus monkey after high frequency stimulation of subthalamic nucleus]. Zhonghua wai ke za zhi [Chinese journal of surgery], 2007, Dec-15, Volume: 45, Issue:24 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acids; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Deep Brain Stimulation; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamic Acid; Macaca mulatta; Microdialysis; Neurotoxins; Neurotransmitter Agents; Parkinson Disease, Secondary; Subthalamic Nucleus; Taurine	2007
Striatal spine plasticity in Parkinson's disease: pathological or not? Parkinsonism & related disorders, 2009, Volume: 15 Suppl 3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cerebral Cortex; Corpus Striatum; Dendritic Spines; Diagnosis, Computer-Assisted; Glutamic Acid; Humans; Neural Pathways; Neuronal Plasticity; Neurons; Parkinson Disease; Parkinson Disease, Secondary; Synaptic Transmission	2009
Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss. Cerebral cortex (New York, N.Y. : 1991), 2010, Volume: 20, Issue:10 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Cerebral Cortex; Corpus Striatum; Dendrites; Disease Models, Animal; Dopamine; Excitatory Amino Acid Agents; Fluoresceins; Glutamic Acid; Male; Neurons; Organ Culture Techniques; Organic Chemicals; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Silver Staining	2010
Metabolic changes detected in vivo by 1H MRS in the MPTP-intoxicated mouse. NMR in biomedicine, 2010, Volume: 23, Issue:6 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Dopamine; Dopamine Agents; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Levodopa; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred C57BL; Neurotoxins; Protons	2010
In vitro study of neuroprotective properties of GK-2, a new original nerve growth factor mimetic. Bulletin of experimental biology and medicine, 2011, Volume: 150, Issue:5 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dipeptides; Glutamic Acid; Hydrogen Peroxide; Mice; Nerve Growth Factor; Neurons; Neuroprotective Agents; Neurotoxins; Oxidative Stress; PC12 Cells; Primary Cell Culture; Rats	2011
Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Behavioural brain research, 2012, Dec-01, Volume: 235, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Intranasal; Agmatine; Analysis of Variance; Animals; Disease Models, Animal; Dopaminergic Neurons; Drug Administration Schedule; Drug Interactions; Exploratory Behavior; Female; Glutamic Acid; Hippocampus; Mice; Mice, Inbred C57BL; Motor Activity; Neurologic Examination; Neuroprotective Agents; Parkinsonian Disorders; Recognition, Psychology; Social Behavior; Substantia Nigra; Survival Analysis; Tritium; Tyrosine 3-Monooxygenase	2012
Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Journal of neuroscience research, 2015, Volume: 93, Issue:12 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Brain; Cognition Disorders; Disease Models, Animal; Executive Function; Gait Disorders, Neurologic; Gene Expression Regulation; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Neuropsychological Tests; Tyrosine 3-Monooxygenase; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2	2015
Mapping the alterations in glutamate with GluCEST MRI in a mouse model of dopamine deficiency. Journal of neurochemistry, 2016, Volume: 139, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Astrocytes; Brain Chemistry; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Glial Fibrillary Acidic Protein; Gliosis; Glutamic Acid; Hand Strength; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neostriatum; Tyrosine 3-Monooxygenase; Vesicular Glutamate Transport Protein 1	2016
Effect of L-pGlu-(1-benzyl)-l-His-l-Pro-NH Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 84 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Ischemia; Catalepsy; Cell Death; Disease Models, Animal; Glucose; Glutamic Acid; Haloperidol; Hippocampus; Inflammation Mediators; Lipid Peroxidation; Male; Memory Disorders; Mice; Models, Biological; Motor Activity; Neurons; Oxygen; PC12 Cells; Rats; Scopolamine; Thyrotropin-Releasing Hormone	2016
Regulation of glutamate transporter trafficking by Nedd4-2 in a Parkinson's disease model. Cell death & disease, 2017, 02-02, Volume: 8, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Amino Acid Transport System X-AG; Animals; Astrocytes; Cells, Cultured; Corpus Striatum; Cytoplasm; Disease Models, Animal; Endosomal Sorting Complexes Required for Transport; Glutamic Acid; Male; Membranes; Mesencephalon; Mice; Mice, Inbred C57BL; Nedd4 Ubiquitin Protein Ligases; Parkinson Disease; Protein Kinase C; Protein Serine-Threonine Kinases; Protein Transport; Tyrosine 3-Monooxygenase; Ubiquitin-Protein Ligases; Ubiquitination	2017
In vivo GluCEST MRI: Reproducibility, background contribution and source of glutamate changes in the MPTP model of Parkinson's disease. Scientific reports, 2018, 02-13, Volume: 8, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biological Transport; Disease Models, Animal; Glutamic Acid; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Mice; Neostriatum; Neuroglia; Parkinson Disease; Reproducibility of Results	2018
Astrocytic JWA deletion exacerbates dopaminergic neurodegeneration by decreasing glutamate transporters in mice. Cell death & disease, 2018, 03-02, Volume: 9, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acid Transport System X-AG; Animals; Astrocytes; Carrier Proteins; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Excitatory Amino Acid Transporter 2; Gene Knockout Techniques; Glial Fibrillary Acidic Protein; Glutamic Acid; Heat-Shock Proteins; Male; Membrane Transport Proteins; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; MPTP Poisoning; Neurogenesis; Neurotoxins; Paraquat; Phosphatidylinositol 3-Kinases; STAT3 Transcription Factor	2018
Effect of Anti-Glutamate Antibodies in Modeled Parkinsonian Syndrome. Bulletin of experimental biology and medicine, 2020, Volume: 169, Issue:4 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Intranasal; Animals; Antibodies; Antiparkinson Agents; Autoantibodies; Dopamine; gamma-Globulins; Glutamic Acid; Horses; Hypokinesia; Immunoconjugates; Male; Mice; Mice, Inbred C57BL; Parkinsonian Disorders; Rabbits	2020
Neuropeptide-S affects cognitive impairment and depression-like behavior on MPTP induced experimental mouse model of Parkinson’s disease Turkish journal of medical sciences, 2021, 12-13, Volume: 51, Issue:6 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cognition; Depression; Disease Models, Animal; Dopamine; Glutamic Acid; Glutamine; Mice; Mice, Inbred C57BL; Neuropeptides; Neuroprotective Agents; Parkinson Disease, Secondary	2021